Overview
High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy
Status:
Recruiting
Recruiting
Trial end date:
2024-04-30
2024-04-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
This clinical trial aims to test the participants' tolerance for different concentration iodine solutions during esophageal chromoendoscopy. The main question it aims to answer is: Under the same iodine dosage, do the participants have the same tolerance for 1% and 5% iodine solutions? Participants will be asked to score based on pain and discomfort and describe symptoms and corresponding location at 5 minutes (only for unanesthetized participants) and 30 minutes after chromoendoscopy.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Xijing Hospital of Digestive DiseasesCollaborators:
Air Force 986 Hospital
Ankang Central Hospital
The First Affiliated Hospital of ShiheziI University
Xi'an International Medical Center Hospital
Xianyang Central Hospital (the second people's Hospital of Xianyang City)Treatments:
Cadexomer iodine
Iodine
Lugol's solution
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Patients undergoing esophageal Lugol's iodine chromoendoscopy.
- Age ≥ 18
Exclusion Criteria:
- Patients allergic to iodine or with hyperthyroidism;
- Patients with esophageal varices, esophageal ulcer or other conditions inadvisable for
Lugol chromoendoscopy;
- Patients with severe gastroesophageal reflux disease or reflux symptoms which may
interfered with the outcome measures of current study;
- Patients with postoperative esophageal stenosis affecting endoscopic observation;
- Patients who could not cooperate with the observation and data collection including
patients with mental disorders, severe neurosis, dysgnosia or communication disorder;
- Patients with advanced-stage tumors;
- Patients after upper gastrointestinal surgery;
- Patients who do not agree to sign informed consent forms or follow the trial
requirement.